Patients on simvastatin who find it hard to swallow tablets can now take a liquid formulation. The sugar-free suspension is licensed for the same indications as the tablets:
- Primary hypercholesterolaemia or mixed dyslipidaemia, when the response to diet and other non-pharmacological measures is inadequate
- Homozygous familial hypercholesterolaemia, as an adjunct to diet
- Reduction in risk of cardiovascular mortality and morbidity in patients with atherosclerotic disease or diabetes
It is available in strengths of 20mg/5ml and 40mg/5ml.